Literature DB >> 31995657

Surgical treatment of fibroids for subfertility.

Mostafa Metwally1, Grace Raybould2, Ying C Cheong3, Andrew W Horne4.   

Abstract

BACKGROUND: Fibroids are the most common benign tumours of the female genital tract and are associated with numerous clinical problems including a possible negative impact on fertility. In women requesting preservation of fertility, fibroids can be surgically removed (myomectomy) by laparotomy, laparoscopically or hysteroscopically depending on the size, site and type of fibroid. Myomectomy is however a procedure that is not without risk and can result in serious complications. It is therefore essential to determine whether such a procedure can result in an improvement in fertility and, if so, to then determine the ideal surgical approach.
OBJECTIVES: To examine the effect of myomectomy on fertility outcomes and to compare different surgical approaches. SEARCH
METHODS: We searched the Cochrane Gynaecology and Fertility Group (CGFG) Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, Epistemonikos database, World Health Organization (WHO) International Clinical Trials Registry Platform search portal, Database of Abstracts of Reviews of Effects (DARE), LILACS, conference abstracts on the ISI Web of Knowledge, OpenSigle for grey literature from Europe, and reference list of relevant papers. The final search was in February 2019. SELECTION CRITERIA: Randomised controlled trials (RCTs) examining the effect of myomectomy compared to no intervention or where different surgical approaches are compared regarding the effect on fertility outcomes in a group of infertile women suffering from uterine fibroids. DATA COLLECTION AND ANALYSIS: Data collection and analysis were conducted in accordance with the procedure suggested in the Cochrane Handbook for Systematic Reviews of Interventions. MAIN
RESULTS: This review included four RCTs with 442 participants. The evidence was very low-quality with the main limitations being due to serious imprecision, inconsistency and indirectness. Myomectomy versus no intervention One study examined the effect of myomectomy compared to no intervention on reproductive outcomes. We are uncertain whether myomectomy improves clinical pregnancy rate for intramural (odds ratio (OR) 1.88, 95% confidence interval (CI) 0.57 to 6.14; 45 participants; one study; very low-quality evidence), submucous (OR 2.04, 95% CI 0.62 to 6.66; 52 participants; one study; very low-quality evidence), intramural/subserous (OR 2.00, 95% CI 0.40 to 10.09; 31 participants; one study; very low-quality evidence) or intramural/submucous fibroids (OR 3.24, 95% CI 0.72 to 14.57; 42 participants; one study; very low-quality evidence). Similarly, we are uncertain whether myomectomy reduces miscarriage rate for intramural fibroids (OR 1.33, 95% CI 0.26 to 6.78; 45 participants; one study; very low-quality evidence), submucous fibroids (OR 1.27, 95% CI 0.27 to 5.97; 52 participants; one study; very low-quality evidence), intramural/subserous fibroids (OR 0.80, 95% CI 0.10 to 6.54; 31 participants; one study; very low-quality evidence) or intramural/submucous fibroids (OR 2.00, 95% CI 0.32 to 12.33; 42 participants; one study; very low-quality evidence). This study did not report on live birth, preterm delivery, ongoing pregnancy or caesarean section rate. Laparoscopic myomectomy versus myomectomy by laparotomy or mini-laparotomy Two studies compared laparoscopic myomectomy to myomectomy at laparotomy or mini-laparotomy. We are uncertain whether laparoscopic myomectomy compared to laparotomy or mini-laparotomy improves live birth rate (OR 0.80, 95% CI 0.42 to 1.50; 177 participants; two studies; I2 = 0%; very low-quality evidence), preterm delivery rate (OR 0.70, 95% CI 0.11 to 4.29; participants = 177; two studies; I2 = 0%, very low-quality evidence), clinical pregnancy rate (OR 0.96, 95% CI 0.52 to 1.78; 177 participants; two studies; I2 = 0%, very low-quality evidence), ongoing pregnancy rate (OR 1.61, 95% CI 0.26 to 10.04; 115 participants; one study; very low-quality evidence), miscarriage rate (OR 1.25, 95% CI 0.40 to 3.89; participants = 177; two studies; I2 = 0%, very low-quality evidence), or caesarean section rate (OR 0.69, 95% CI 0.34 to 1.39; participants = 177; two studies; I2 = 21%, very low-quality evidence). Monopolar resectoscope versus bipolar resectoscope One study evaluated the use of two electrosurgical systems during hysteroscopic myomectomy. We are uncertain whether bipolar resectoscope use compared to monopolar resectoscope use improves live birth/ongoing pregnancy rate (OR 0.86, 95% CI 0.30 to 2.50; 68 participants; one study, very low-quality evidence), clinical pregnancy rate (OR 0.88, 95% CI 0.33 to 2.36; 68 participants; one study; very low-quality evidence), or miscarriage rate (OR 1.00, 95% CI 0.19 to 5.34; participants = 68; one study; very low-quality evidence). This study did not report on preterm delivery or caesarean section rate. AUTHORS'
CONCLUSIONS: There is limited evidence to determine the role of myomectomy for infertility in women with fibroids as only one trial compared myomectomy with no myomectomy. If the decision is made to have a myomectomy, the current evidence does not indicate a superior method (laparoscopy, laparotomy or different electrosurgical systems) to improve rates of live birth, preterm delivery, clinical pregnancy, ongoing pregnancy, miscarriage, or caesarean section. Furthermore, the existing evidence needs to be viewed with caution due to the small number of events, minimal number of studies and very low-quality evidence.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 31995657      PMCID: PMC6989141          DOI: 10.1002/14651858.CD003857.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  60 in total

Review 1.  Laparoscopic myomectomy: a current view.

Authors:  J B Dubuisso; A Fauconnier; K Babaki-Fard; C Chapron
Journal:  Hum Reprod Update       Date:  2000 Nov-Dec       Impact factor: 15.610

Review 2.  Hysteroscopic myomectomy: a comprehensive review of surgical techniques.

Authors:  Attilio Di Spiezio Sardo; Ivan Mazzon; Silvia Bramante; Stefano Bettocchi; Giuseppe Bifulco; Maurizio Guida; Carmine Nappi
Journal:  Hum Reprod Update       Date:  2007-12-06       Impact factor: 15.610

3.  Myomectomy: indications, results of surgery and relation to fertility.

Authors:  R K Chong; P H Thong; S L Tan; P W Thong; Y M Salmon
Journal:  Singapore Med J       Date:  1988-02       Impact factor: 1.858

4.  Fertility outcome: long-term results after laparoscopic myomectomy.

Authors:  A Rossetti; O Sizzi; L Soranna; S Mancuso; A Lanzone
Journal:  Gynecol Endocrinol       Date:  2001-04       Impact factor: 2.260

5.  Determinants of reproductive outcome after abdominal myomectomy for infertility.

Authors:  P Vercellini; S Maddalena; O De Giorgi; A Pesole; L Ferrari; P G Crosignani
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

6.  Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women.

Authors:  N N Varasteh; R S Neuwirth; B Levin; M D Keltz
Journal:  Obstet Gynecol       Date:  1999-08       Impact factor: 7.661

7.  A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes.

Authors:  Stefano Palomba; Errico Zupi; Angela Falbo; Tiziana Russo; Daniela Marconi; Achille Tolino; Francesco Manguso; Alberto Mattei; Fulvio Zullo
Journal:  Fertil Steril       Date:  2007-04-16       Impact factor: 7.329

8.  Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility.

Authors:  P Vercellini; B Zàina; L Yaylayan; A Pisacreta; O De Giorgi; P G Crosignani
Journal:  Obstet Gynecol       Date:  1999-09       Impact factor: 7.661

9.  Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids.

Authors:  O Yoshino; T Hayashi; Y Osuga; M Orisaka; H Asada; S Okuda; M Hori; M Furuya; H Onuki; Y Sadoshima; H Hiroi; T Fujiwara; F Kotsuji; Y Yoshimura; O Nishii; Y Taketani
Journal:  Hum Reprod       Date:  2010-08-18       Impact factor: 6.918

Review 10.  Fibroids and infertility: an updated systematic review of the evidence.

Authors:  Elizabeth A Pritts; William H Parker; David L Olive
Journal:  Fertil Steril       Date:  2008-03-12       Impact factor: 7.329

View more
  5 in total

1.  Route of myomectomy and fertility: a prospective cohort study.

Authors:  Lauren A Wise; Laine Thomas; Sophia Anderson; Donna D Baird; Raymond M Anchan; Kathryn L Terry; Erica E Marsh; Ganesa Wegienka; Wanda Kay Nicholson; Kedra Wallace; Robert Bigelow; James Spies; George L Maxwell; Vanessa Jacoby; Evan R Myers; Elizabeth A Stewart
Journal:  Fertil Steril       Date:  2022-02-23       Impact factor: 7.490

Review 2.  The Impact of Uterine Fibroids on Fertility: How the Uncertainty Widens the Gap in Reproductive Outcomes in Black Women.

Authors:  Chelsea A Henshaw; Mariam H Goreish; Megan E Gornet; Chantel I Cross
Journal:  Reprod Sci       Date:  2022-02-24       Impact factor: 2.924

3.  Comparison of (Cost-)Effectiveness of Magnetic Resonance Image-Guided High-Intensity-Focused Ultrasound With Standard (Minimally) Invasive Fibroid Treatments: Protocol for a Multicenter Randomized Controlled Trial (MYCHOICE).

Authors:  Kimberley J Anneveldt; Ingrid M Nijholt; Joke M Schutte; Jeroen R Dijkstra; Geert W J Frederix; Erwin Ista; Inez M Verpalen; Sebastiaan Veersema; Judith A F Huirne; Wouter J K Hehenkamp; Martijn F Boomsma
Journal:  JMIR Res Protoc       Date:  2021-11-24

Review 4.  Uterine Fibroids and Pregnancy: How Do They Affect Each Other?

Authors:  Larissa M Coutinho; Wiviane A Assis; Ananda Spagnuolo-Souza; Fernando M Reis
Journal:  Reprod Sci       Date:  2021-06-17       Impact factor: 2.924

5.  Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.

Authors:  Yonghui Yu; Fang Yang; Hong Liu
Journal:  Biosci Rep       Date:  2020-12-23       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.